Oklahoma Heart Institute is a clinical research site located in Tulsa, Oklahoma, United States 74104.
Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.
Oklahoma Heart Institute has participated in 52 clinical trials with 21 currently active.
Therapeutic areas: Aortic Valve Stenosis, Degenerative Mitral Valve Disease, Mitral Regurgitation.
Sponsors: National Heart, Lung, and Blood Institute (NHLBI), Edwards Lifesciences, Akebia Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oklahoma · View every site in Tulsa
Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Oklahoma Heart Institute has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oklahoma Heart Institute has 52 clinical trials on record, with 21 currently active. Their work covers Aortic Valve Stenosis, Degenerative Mitral Valve Disease, Mitral Regurgitation.
Oklahoma Heart Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.